A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer
- PMID: 12734058
- DOI: 10.1207/S15327914NC4402_02
A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer
Abstract
Epidemiological studies have identified body weight as a risk factor for breast cancer. Beyond the amount of adipose tissue a woman has, its distribution, particularly abdominally, may be a risk factor in breast cancer etiology. Body fat distribution is commonly measured by a waist-to-hip circumference ratio lpar;WHR). We performed a meta-analysis to summarize the published literature on WHR and breast cancer risk. After assembling all published studies, we extracted mean WHRs for study participants and adjusted risk estimates comparing highest with lowest partition of WHR and calculated weighted mean differences in WHR between cases and noncases and summary risk estimates based on study design and menopausal status. The weighted mean difference was 0.016 [95% confidence interval (CI) = 0.005-0.028] for all studies combined. The summary risk estimates were 1.80 (95% CI = 1.29-2.50) for case-control studies and 1.27 (95% CI = 1.07-1.51) for cohort studies. By menopausal status, the summary risks were 1.79 (95% CI = 1.22-2.62) for premenopausal women and 1.50 (95% CI = 1.10-2.04) for postmenopausal women. For all studies combined, the summary risk was 1.62 (95% CI = 1.28-2.04). This meta-analysis indicates that a greater WHR is associated with increased risk of breast cancer and suggests that the avoidance of abdominal obesity may reduce risk of the disease.
Similar articles
-
Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1566-73. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12496045
-
[Anthropometry and female breast cancer: a prospective cohort study in urban Shanghai].Zhonghua Liu Xing Bing Xue Za Zhi. 2006 Jun;27(6):488-93. Zhonghua Liu Xing Bing Xue Za Zhi. 2006. PMID: 17152508 Chinese.
-
A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancer.Mol Carcinog. 1996 Nov;17(3):144-50. doi: 10.1002/(SICI)1098-2744(199611)17:3<144::AID-MC6>3.0.CO;2-F. Mol Carcinog. 1996. PMID: 8944074
-
Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis.Breast Cancer Res Treat. 2010 Oct;123(3):641-9. doi: 10.1007/s10549-010-1116-4. Epub 2010 Aug 15. Breast Cancer Res Treat. 2010. PMID: 20711809 Review.
-
Central obesity and risks of pre- and postmenopausal breast cancer: a dose-response meta-analysis of prospective studies.Obes Rev. 2016 Nov;17(11):1167-1177. doi: 10.1111/obr.12443. Epub 2016 Jul 19. Obes Rev. 2016. PMID: 27432212 Review.
Cited by
-
Insulin Resistance: The Increased Risk of Cancers.Curr Oncol. 2024 Feb 13;31(2):998-1027. doi: 10.3390/curroncol31020075. Curr Oncol. 2024. PMID: 38392069 Free PMC article. Review.
-
Urine levels of estrogen and its metabolites in premenopausal middle-aged women with different degrees of obesity and their correlation with glucose and lipid metabolism.Heliyon. 2023 Nov 15;9(11):e22362. doi: 10.1016/j.heliyon.2023.e22362. eCollection 2023 Nov. Heliyon. 2023. PMID: 38058651 Free PMC article.
-
The relationship between central obesity and risk of breast cancer: a dose-response meta-analysis of 7,989,315 women.Front Nutr. 2023 Nov 9;10:1236393. doi: 10.3389/fnut.2023.1236393. eCollection 2023. Front Nutr. 2023. PMID: 38024370 Free PMC article.
-
Risk factors for the development of triple-negative breast cancer versus non-triple-negative breast cancer: a case-control study.Sci Rep. 2023 Aug 20;13(1):13551. doi: 10.1038/s41598-023-40443-8. Sci Rep. 2023. PMID: 37599285 Free PMC article.
-
Measured body size and serum estrogen metabolism in postmenopausal women: the Ghana Breast Health Study.Breast Cancer Res. 2022 Jan 26;24(1):9. doi: 10.1186/s13058-022-01500-8. Breast Cancer Res. 2022. PMID: 35081987 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical